Related Experiment Videos

Neonatal diagnosis of Prader-Willi syndrome and its implications

F Greenberg1, F F Elder, D H Ledbetter

  • 1Institute for Molecular Genetics, Baylor College of Medicine, Houston, Texas 77030.

Insights

Early cytogenetic analysis confirms Prader-Willi syndrome (PWS) in hypotonic infants. This diagnosis is crucial for preventing obesity and developmental issues, though parental counseling remains challenging.

Area of Science:

  • Genetics
  • Pediatrics
  • Medical Diagnostics

Background:

  • Prader-Willi syndrome (PWS) is characterized by neonatal hypotonia, feeding difficulties, followed by hyperphagia, obesity, and intellectual disability.
  • Cytogenetic analysis revealing deletions in chromosome 15q11-q13 is a key diagnostic marker for PWS.

Purpose of the Study:

  • To confirm the diagnosis of Prader-Willi syndrome in infants presenting with hypotonia.
  • To evaluate the utility of cytogenetic analysis for early PWS detection.

Main Methods:

  • Clinical assessment of hypotonic infants for PWS suspicion.
  • High-resolution cytogenetic analysis to detect monosomy of 15q11-q13.

Main Results:

  • Cytogenetic studies confirmed monosomy of 15q11-q13 in all 5 hypotonic infants suspected of PWS.
  • Early diagnosis was achieved within the first three months of life.

Conclusions:

  • Cytogenetic analysis is a reliable method for the early diagnosis of Prader-Willi syndrome in at-risk infants.
  • Early PWS diagnosis facilitates timely intervention to prevent obesity and manage developmental concerns.
  • The cost-effectiveness and practicality of widespread screening require systematic evaluation.

Related Concept Videos